Enhanced m6A leads to compensatory myocardial hypertrophy, while inhibition of m6A leads to muscle cell remodeling and dysfunction, highlighting the importance of METTL3-mediated methylation of m6A mRNA for maintaining normal cardiac function. The gene discussed is METTL3; the disease is hypertrophy.